NeuroOne Medical Technologies is a medical device company focused on advancing neural interface technologies for diagnostic and therapeutic applications. The company’s proprietary NeuroOne Ultracompliant Solution (NUS®) platform features a flexible polymer microelectrode array designed to conform to delicate neural tissue. By combining high-fidelity recording and precise stimulation capabilities, NeuroOne aims to improve outcomes for patients suffering from chronic pain, movement disorders and other neurological conditions.
At the core of NeuroOne’s product pipeline is the MicroLead® neural interface, a next-generation device engineered to enhance the safety and efficacy of spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS). The MicroLead’s ultrathin, biocompatible design minimizes tissue trauma while enabling higher resolution mapping of neural signals. The company is also developing complementary implantation and delivery systems to streamline surgical procedures and support broader clinical adoption.
Since its inception in 2015, NeuroOne has built a portfolio of patents covering its polymer electrode technology, system architectures and manufacturing processes. The company is headquartered in Cleveland, Ohio, with manufacturing facilities in Costa Rica, and collaborates with leading academic medical centers across North America and Europe. Through clinical trials and research partnerships, NeuroOne seeks to validate its platform’s potential in diverse therapeutic areas, including neuromodulation for epilepsy, Parkinson’s disease and refractory pain syndromes.
NeuroOne’s leadership team combines deep expertise in neurosurgery, biomedical engineering and medical device commercialization. Under the guidance of President and Chief Executive Officer David Backes, the company has expanded its R&D footprint and secured key regulatory designations. With an experienced board of directors and a growing pipeline of proprietary assets, NeuroOne Medical Technologies is positioned to play a pivotal role in the evolution of next-generation neural interfaces.
AI Generated. May Contain Errors.